RASSF1 and cancer: Our results that AZA and TSA treated H1299 cancer cell changed the chromatin structure nearby the RASSF1A promoter, but not upstream of the CTCF binding sites between RASSF1A and BLU loci supported their mechanisms [41]–[43].